Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 04-Apr-24 4:14 PM View:  | de Backer Marianne Chief Executive Officer Director | Vir Biotechnology, Inc. (VIR) | 03-Apr-24 | Sale | 72,995 | $9.46 | $690,365.00 | (10%) 751.45K to 678.46K | |
| 02-Apr-24 8:58 PM View: | Hanly Ann M. EVP & Chief Technology Officer | Vir Biotechnology, Inc. (VIR) | 01-Apr-24 | Sale | 2,711 | $10.05 | $27,251.00 | (2%) 134.79K to 132.08K | |
| 28-Mar-24 12:18 PM View: | Lee Sung EVP & Chief Financial Officer | Vir Biotechnology, Inc. (VIR) | 27-Mar-24 | Sale | 6,008 | $9.89 | $59,404.10 | (6%) 106.5K to 100.49K | |
| 26-Feb-24 7:30 PM View: | Scangos George A Director | Vir Biotechnology, Inc. (VIR) | 26-Feb-24 | Sale (Planned) | 17,722 | $11.65 | $206,522.00 | (< 1%) 3.84M to 3.83M | |
| 26-Feb-24 7:30 PM View: | Scangos George A Director | Vir Biotechnology, Inc. (VIR) | 22-Feb-24 | Sale | 10,028 | $10.05 | $100,737.00 | (< 1%) 3.85M to 3.84M | |
| 26-Feb-24 7:34 PM View: | Hanly Ann M. EVP & Chief Technology Officer | Vir Biotechnology, Inc. (VIR) | 22-Feb-24 | Grant | 32,500 | -- | -- | 28% 114.59K to 147.09K | |
| 26-Feb-24 7:31 PM View: | Pang Phillip EVP & Chief Medical Officer | Vir Biotechnology, Inc. (VIR) | 22-Feb-24 | Sale | 14,568 | $10.05 | $146,344.00 | (6%) 264.68K to 250.11K | |
| 26-Feb-24 7:32 PM View: | de Backer Marianne Chief Executive Officer Director | Vir Biotechnology, Inc. (VIR) | 22-Feb-24 | Grant | 175,000 | -- | -- | 30% 576.45K to 751.45K | |
| 26-Feb-24 7:34 PM View: | Hanly Ann M. EVP & Chief Technology Officer | Vir Biotechnology, Inc. (VIR) | 22-Feb-24 | Sale | 12,296 | $10.05 | $123,521.00 | (8%) 147.09K to 134.79K | |
| 26-Feb-24 7:32 PM View: | Lee Sung EVP & Chief Financial Officer | Vir Biotechnology, Inc. (VIR) | 22-Feb-24 | Grant | 40,000 | -- | -- | 60% 66.5K to 106.5K | |
| 20-Feb-24 9:02 PM View: | Scangos George A Director | Vir Biotechnology, Inc. (VIR) | 20-Feb-24 | Sale (Planned) | 16,872 | $10.22 | $172,385.00 | (< 1%) 3.87M to 3.85M | |
| 16-Feb-24 6:56 PM View: | Pang Phillip EVP & Chief Medical Officer | Vir Biotechnology, Inc. (VIR) | 16-Feb-24 | Sale | 3,321 | $10.24 | $34,005.70 | (1%) 268.0K to 264.68K | |
| 20-Feb-24 9:02 PM View: | Scangos George A Director | Vir Biotechnology, Inc. (VIR) | 16-Feb-24 | Sale | 10,878 | $10.24 | $111,386.00 | (< 1%) 3.88M to 3.87M | |
| 03-Jan-24 2:47 PM View: | Pang Phillip EVP & Chief Medical Officer | Vir Biotechnology, Inc. (VIR) | 02-Jan-24 | Option Exercise | 80,000 | $1.38 | $110,299.00 | 43% 188.0K to 268.0K | |
| 20-Oct-23 2:15 PM View: | More Robert J Director | Vir Biotechnology, Inc. (VIR) | 19-Oct-23 | Acquisition (other) | 6,405 | -- | -- | 1% 534.57K to 540.98K | |
| 20-Oct-23 2:15 PM View: | More Robert J Director | Vir Biotechnology, Inc. (VIR) | 19-Oct-23 | Disposition (other) | 6,405 | -- | -- | (1%) 540.98K to 534.57K | |
| 18-Oct-23 2:14 PM View: | Scangos George A Director | Vir Biotechnology, Inc. (VIR) | 17-Oct-23 | Disposition (other) | 1,750,000 | -- | -- | (31%) 5.63M to 3.88M | |
| 18-Oct-23 2:14 PM View: | Scangos George A Director | Vir Biotechnology, Inc. (VIR) | 17-Oct-23 | Acquisition (other) | 3,500,000 | -- | -- | 90% 3.88M to 7.38M | |
| 18-Oct-23 2:14 PM View: | Scangos George A Director | Vir Biotechnology, Inc. (VIR) | 17-Oct-23 | Disposition (other) | 1,750,000 | -- | -- | (24%) 7.38M to 5.63M | |
| 18-Sep-23 3:54 PM View: | Scangos George A Director | Vir Biotechnology, Inc. (VIR) | 15-Sep-23 | Disposition (other) | 5,377,590 | -- | -- | (58%) 9.26M to 3.88M | |
| 18-Sep-23 3:54 PM View: | Scangos George A Director | Vir Biotechnology, Inc. (VIR) | 15-Sep-23 | Acquisition (other) | 1,750,000 | -- | -- | 30% 5.76M to 7.51M | |
| 18-Sep-23 3:54 PM View: | Scangos George A Director | Vir Biotechnology, Inc. (VIR) | 15-Sep-23 | Acquisition (other) | 1,750,000 | -- | -- | 23% 7.51M to 9.26M | |
| 05-Jul-23 10:00 PM View: | Svf Endurance (cayman) Ltd 10% Owner | Vir Biotechnology, Inc. (VIR) | 30-Jun-23 | Sale (Planned) | 700 | $25.11 | $17,577.00 | (< 1%) 16.68M to 16.68M | |
| 03-Jul-23 4:15 PM View: | Sato Vicki L Director | Vir Biotechnology, Inc. (VIR) | 30-Jun-23 | Sale (Planned) | 18,000 | $24.66 | $443,916.00 | (1%) 1.33M to 1.32M | |
| 30-Jun-23 9:00 PM View: | Svf Endurance (cayman) Ltd 10% Owner | Vir Biotechnology, Inc. (VIR) | 29-Jun-23 | Sale (Planned) | 89,942 | $25.18 | $2,264,730.00 | (< 1%) 16.77M to 16.68M | |
| 30-Jun-23 9:00 PM View: | Svf Endurance (cayman) Ltd 10% Owner | Vir Biotechnology, Inc. (VIR) | 28-Jun-23 | Sale (Planned) | 7,010 | $25.10 | $175,922.00 | (< 1%) 16.78M to 16.77M | |
| 22-Jun-23 9:00 PM View: | Svf Endurance (cayman) Ltd 10% Owner | Vir Biotechnology, Inc. (VIR) | 20-Jun-23 | Sale (Planned) | 9,902 | $25.18 | $249,302.00 | (< 1%) 16.79M to 16.78M | |
| 15-Jun-23 9:00 PM View: | Svf Endurance (cayman) Ltd 10% Owner | Vir Biotechnology, Inc. (VIR) | 14-Jun-23 | Sale (Planned) | 57,248 | $26.13 | $1,495,620.00 | (< 1%) 17.03M to 16.97M | |
| 15-Jun-23 9:00 PM View: | Svf Endurance (cayman) Ltd 10% Owner | Vir Biotechnology, Inc. (VIR) | 13-Jun-23 | Sale (Planned) | 106,854 | $27.09 | $2,894,180.00 | (< 1%) 17.14M to 17.03M | |
| 08-Jun-23 4:30 PM View: | Pang Phillip Chief Medical Officer | Vir Biotechnology, Inc. (VIR) | 07-Jun-23 | Planned Option Sale | 5,000 | $25.95 | $129,727.00 | (3%) 193.0K to 188.0K | |
| 08-Jun-23 4:30 PM View: | Pang Phillip Chief Medical Officer | Vir Biotechnology, Inc. (VIR) | 07-Jun-23 | Option Exercise | 5,000 | $1.53 | $7,650.00 | 3% 188.0K to 193.0K | |
| 06-Jun-23 10:00 PM View: | Svf Endurance (cayman) Ltd 10% Owner | Vir Biotechnology, Inc. (VIR) | 05-Jun-23 | Sale (Planned) | 5,197 | $27.32 | $141,998.00 | (< 1%) 17.14M to 17.14M | |
| 06-Jun-23 10:00 PM View: | Svf Endurance (cayman) Ltd 10% Owner | Vir Biotechnology, Inc. (VIR) | 02-Jun-23 | Sale (Planned) | 34,365 | $27.32 | $938,732.00 | (< 1%) 17.18M to 17.14M | |
| 02-Jun-23 12:20 PM View: | Rice Steven J. Chief Administrative Officer | Vir Biotechnology, Inc. (VIR) | 01-Jun-23 | Sale (Planned) | 2,500 | $25.67 | $64,175.00 | (2%) 109.34K to 106.84K | |
| 02-Jun-23 12:19 PM View: | Ramasastry Saira Director | Vir Biotechnology, Inc. (VIR) | 01-Jun-23 | Sale (Planned) | 3,500 | $25.67 | $89,845.00 | (25%) 14.12K to 10.62K | |
| 25-May-23 9:00 PM View: | Svf Endurance (cayman) Ltd 10% Owner | Vir Biotechnology, Inc. (VIR) | 24-May-23 | Sale (Planned) | 104,384 | $26.15 | $2,729,600.00 | (< 1%) 17.28M to 17.18M | |
| 25-May-23 9:00 PM View: | Svf Endurance (cayman) Ltd 10% Owner | Vir Biotechnology, Inc. (VIR) | 23-May-23 | Sale (Planned) | 170,067 | $26.66 | $4,533,230.00 | (< 1%) 17.45M to 17.28M | |
| 24-May-23 2:44 PM View: | Ramasastry Saira Director | Vir Biotechnology, Inc. (VIR) | 22-May-23 | Grant | 6,027 | -- | -- | 74% 8.09K to 14.12K | |
| 24-May-23 4:16 PM View: | Nelsen Robert Director 10% Owner | Vir Biotechnology, Inc. (VIR) | 22-May-23 | Grant | 6,027 | -- | -- | < 1% 13.52M to 13.53M | |
| 24-May-23 2:37 PM View: | Sato Vicki L Director | Vir Biotechnology, Inc. (VIR) | 22-May-23 | Grant | 6,027 | -- | -- | < 1% 1.33M to 1.33M | |
| 24-May-23 2:35 PM View: | Sharp Philip A Director | Vir Biotechnology, Inc. (VIR) | 22-May-23 | Grant | 6,027 | -- | -- | 2% 248.48K to 254.51K | |
| 23-May-23 9:00 PM View: | Svf Endurance (cayman) Ltd 10% Owner | Vir Biotechnology, Inc. (VIR) | 22-May-23 | Sale (Planned) | 91,896 | $25.72 | $2,363,900.00 | (< 1%) 17.54M to 17.45M | |
| 24-May-23 2:33 PM View: | Sigal Charles Elliott Director | Vir Biotechnology, Inc. (VIR) | 22-May-23 | Grant | 6,027 | -- | -- | 30% 19.78K to 25.81K | |
| 24-May-23 2:44 PM View: | Perez Robert J Director | Vir Biotechnology, Inc. (VIR) | 22-May-23 | Grant | 6,027 | -- | -- | 62% 9.78K to 15.81K | |
| 24-May-23 2:41 PM View: | More Robert J Director | Vir Biotechnology, Inc. (VIR) | 22-May-23 | Grant | 6,027 | -- | -- | 1% 528.55K to 534.57K | |
| 24-May-23 2:42 PM View: | Napolitano Janet Director | Vir Biotechnology, Inc. (VIR) | 22-May-23 | Grant | 6,027 | -- | -- | 62% 9.78K to 15.81K | |
| 24-May-23 2:34 PM View: | Hatfield Jeffrey S. Director | Vir Biotechnology, Inc. (VIR) | 22-May-23 | Grant | 6,027 | -- | -- | 62% 9.78K to 15.81K | |
| 23-May-23 9:00 PM View: | Svf Endurance (cayman) Ltd 10% Owner | Vir Biotechnology, Inc. (VIR) | 19-May-23 | Sale (Planned) | 91,651 | $25.38 | $2,326,230.00 | (< 1%) 17.64M to 17.54M | |
| 09-May-23 9:00 PM View: | Svf Endurance (cayman) Ltd 10% Owner | Vir Biotechnology, Inc. (VIR) | 05-May-23 | Sale (Planned) | 136 | $25.10 | $3,414.04 | (< 1%) 17.64M to 17.64M | |
| 05-May-23 9:00 PM View: | Svf Endurance (cayman) Ltd 10% Owner | Vir Biotechnology, Inc. (VIR) | 04-May-23 | Sale (Planned) | 114,332 | $25.55 | $2,921,160.00 | (< 1%) 17.75M to 17.64M |
